Contrasting Global and Patient-Specific Regression Models via a Neural Network Representation

Technical Summary: Contrasting Global and Patient-Specific Regression Models via a Neural Network Representation

Problem Statement
In clinical research, regression models are standard for linking patient characteristics to outcomes. However, a "global" model fitted to an entire dataset often assumes uniform relationships across all patients, potentially masking heterogeneity where specific subgroups or individuals require different parameter values. While random effects models account for variability, they do not necessarily capture distinct regions in the predictor space requiring different parameters. Traditional methods to detect such deviations, such as adding interaction terms, become computationally unwieldy and statistically unstable when the number of predictors is large relative to the sample size (the "small data" setting). Furthermore, existing subgroup discovery methods, such as tree-based approaches or Exceptional Model Mining, often fail to leverage the smooth variation of regression parameters across the predictor space or do not provide personalized models for regions outside identified stable subgroups. A significant challenge arises when attempting localized regression in high-dimensional spaces (e.g., $p=76$ predictors), where the "curse of dimensionality" renders the concept of local neighborhoods sparse and ineffective.

Methodology
The authors propose a diagnostic tool that contrasts a global regression model with patient-specific (local) regression models within a unified, low-dimensional latent space. The core methodology involves three integrated components:

1. Autoencoder-Based Dimensionality Reduction: To overcome the curse of dimensionality, the method employs an autoencoder neural network to map the original high-dimensional predictor space ($X \in \mathbb{R}^{n \times p}$) into a lower-dimensional latent space ($Z \in \mathbb{R}^{n \times d}$, where $d \ll p$). Unlike standard dimensionality reduction, this is not a two-step process.
2. End-to-End Training with a Composite Loss Function: The autoencoder is trained using a composite loss function that simultaneously optimizes for:
   • Data Reconstruction ($Loss_{rec}$): Minimizing the mean squared error between the original input and the decoder's reconstruction to ensure the latent space retains meaningful data structure.
   • Outcome Prediction ($Loss_{pred}$): Maximizing the likelihood of a localized regression model. For each patient, a local weighted regression is fitted in the latent space. The loss compares the likelihood of this patient-specific model against a patient-specific null model (intercept-only). This ensures the latent representation is structured to reveal local outcome-related associations.
3. Local Regression and Subgroup Identification: Within the learned latent space, localized regression models are fitted for each patient using kernel-weighted nearest neighbors (specifically a Gaussian kernel). The coefficients of these local models are compared against a single global model fitted to the entire latent space. Patients whose local coefficients deviate significantly from the global coefficients (falling outside global confidence intervals) are flagged. These patients are then clustered into subgroups based on consistent patterns of deviation. Finally, these subgroups are characterized by mapping the latent deviations back to the original predictor space using interaction analyses and Z-score profiles.

Key Contributions

• Novel Diagnostic Framework: The paper introduces a method to systematically identify where and for whom a global regression model is inadequate, bridging the gap between global interpretability and personalized modeling.
• Outcome-Guided Latent Representation: By integrating the prediction task directly into the autoencoder's training via a composite loss function, the method learns a latent space that is optimized not just for data compression, but for revealing local relationships between predictors and clinical outcomes.
• Mitigation of Dimensionality Issues: The approach successfully enables localized regression in settings with many predictors relative to sample size by performing localization in a dense, low-dimensional manifold rather than the sparse original space.
• Interpretability: The method provides a mechanism to translate findings from the latent space back to the original clinical variables, offering insights into why specific subgroups deviate from the global model.

Results
The approach was evaluated on a clinical dataset of 217 patients with chronic obstructive pulmonary disease (COPD) with 76 physiological predictors and the St. George's Respiratory Questionnaire (SGRQ) score as the outcome.

• Model Performance: The proposed method achieved a global latent model $R^2$ of 0.41, significantly outperforming a Principal Component Analysis (PCA) approach ($R^2 = 0.19$) and a standard autoencoder trained only for reconstruction ($R^2 = 0.15$).
• Subgroup Discovery: The method identified two distinct subgroups of patients (30 and 20 patients, respectively) whose local regression coefficients diverged significantly from the global model.
  • Subgroup 1: Characterized by lower body weight and higher lung capacity percentages, showing significant interaction effects in lung function measures.
  • Subgroup 2: Characterized by higher lung flow and diffusion capacity but lower expiratory reserve, showing distinct relationships with intrathoracic gas volume.
• Predictive Gain: For the identified subgroups, the localized models reduced the Root Mean Squared Error (RMSE) by 0.10 and 0.16, respectively, representing a substantially larger improvement than the marginal gains seen for the rest of the cohort.
• Stability and Generalization: The identified subgroups remained stable across 15 different random seed initializations. Furthermore, when applied to a separate test set, the latent space and subgroup characteristics generalized well, preserving the distinct clinical profiles and interaction effects.
• Comparison to Stepwise Regression: While a traditional stepwise regression with interaction search identified effects related to the first subgroup, it failed to detect the second subgroup (gas trapping effects). This highlights the proposed method's ability to uncover localized effects that lack strong global main effects, which traditional variable selection often filters out.

Significance and Claims
The authors claim that their primary contribution is a diagnostic tool rather than a replacement for global modeling. The significance lies in its ability to:

1. Quantify Adequacy: Provide a data-driven assessment of when a "one-size-fits-all" global model is sufficient and when it fails.
2. Identify Hidden Heterogeneity: Detect clinically relevant subgroups defined by complex, localized interactions that are missed by standard global model-building techniques (like stepwise regression) which rely on strong global main effects.
3. Enhance Interpretability: Offer a pathway to understand why a global model fails for specific patients by mapping latent deviations back to original clinical variables.

The paper positions this approach as a complement to existing biostatistical practices, offering a flexible way to explore personalized medicine in complex, small-data clinical settings without the instability of high-dimensional interaction modeling. The authors note that while the current implementation is exploratory, future work could extend the framework to formal statistical inference and other outcome types.